SCHEMBL2215952

SCHEMBL2215952

CCC(=O)Nc1cc(C(=O)Nc2ccc(OC)cc2)ccc1OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 3/20 0.63
HDAC1 Q13547 2/20 0.63
HDAC6 Q9UBN7 2/20 0.63
TP53 P04637 3/20 0.61
GAA P10253 1/20 0.61
MAPT P10636 4/20 0.60
ALDH1A1 P00352 3/20 0.60
KDM4E B2RXH2 2/20 0.60
HTT P42858 1/20 0.60
NPC1 O15118 4/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
RAB9A P51151 3/20 0.60
MAPK1 P28482 3/20 0.59
ALOX15 P16050 1/20 0.58
TSHR P16473 1/20 0.57
CYP2C9 P11712 1/20 0.57
RXFP1 Q9HBX9 1/20 0.57
CYP1A2 P05177 1/20 0.56
AHR P35869 1/20 0.56
CASP3 P42574 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2217357 0.89 HDAC8 (0.64) HDAC8HDAC1HDAC6MAPTALDH1A1
SCHEMBL17507496 0.89 HDAC8 (0.62) HDAC8HDAC1HDAC6TP53GAA
SCHEMBL17507526 0.87 KMT2A (0.63) TP53MAPTALDH1A1HTTNPC1
SCHEMBL17507482 0.86 NPC1 (0.61) HDAC8HDAC1HDAC6TP53GAA
SCHEMBL12436031 0.85 MAPK1 (0.57) TP53GAAMAPTALDH1A1KDM4E
SCHEMBL2217242 0.85 MAPT (0.56) HDAC8HDAC1HDAC6TP53GAA
SCHEMBL17507527 0.85 MAPT (0.56) HDAC8HDAC1HDAC6TP53GAA
SCHEMBL2218409 0.85 KMT2A (0.72) MAPTALDH1A1HTTNPC1SMN1; SMN2
SCHEMBL17507485 0.84 NPC1 (0.66) HDAC8HDAC1HDAC6TP53GAA
SCHEMBL17512400 0.82 HDAC8 (0.63) HDAC8HDAC1HDAC6TP53GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2351731-B1 A GROUP OF AMINO SUBSTITUTED BENZOYL DERIVATIVES AND THEIR PREPARATION AND THEIR USE INST MED BIOTECHNOLOGY CAMS (CN) 2016-02-10 EP disclosed
US-8710098-B2 Group of amino substituted benzoyl derivatives and their preparation and their use Institute of Medicinal Biotechnology Chinese Academy of Medical Science (CN) 2014-04-29 US disclosed
EP-2351731-A1 A GROUP OF AMINO SUBSTITUTED BENZOYL DERIVATIVES AND THEIR PREPARATION AND THEIR USE Institute Of Medicinal Biotechnology, Chinese Academy of Medical Sciences (CN) 2011-08-03 EP disclosed
US-20110178108-A1 Group of amino substituted benzoyl derivatives and their preparation and their use Institute of Medicinal Biotechnology Academy of Medical Science (CN) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178108-A1 Group of amino substituted benzoyl derivatives and their preparation and their use CUL3, APOBEC3G, BRPF3 HDAC8 1480/4885HDAC1 1555/4885HDAC6 1569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.